Park Ha Biological Technology Co
BYAH
4 hedge funds and large institutions have $666K invested in Park Ha Biological Technology Co in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
33% more capital invested
Capital invested by funds: $502K → $666K (+$165K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.11% less ownership
Funds ownership: 0.31% → 0.19% (-0.11%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$114K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$16.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$161K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$87.1K |
| 3 |
HF
HRT Financial
New York
|
-$46.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$19.4K |
BYAH Hedge Fund Activity: Q1 2025 in Review
4 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q1 2025, worth a combined $666K — up 33% from $502K a quarter earlier.
Fund positioning in BYAH was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $114K. The largest seller was Jane Street, exiting entirely with an estimated $161K sold.
- 4 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $666K of Park Ha Biological Technology Co stock for Q1 2025, up 33% quarter-over-quarter.
- 2 funds opened new Park Ha Biological Technology Co positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest Park Ha Biological Technology Co buyer in Q1 2025 was Geode Capital Management, an estimated $114K added.
- The largest Park Ha Biological Technology Co seller in Q1 2025 was Jane Street, an estimated $161K sold.
Based on aggregated 13F filings for Q1 2025.